Structures and Biological Activities of Tobramycin‐Ticarcillin Adducts
Aminoglycosides and penicillins chemically interact when they are combinedin vitroorin vivo.The resulting adducts are considered to be biologically inactive. The major adducts formed in the interaction between tobramycin and ticarcillin have been recently isolated in pure form in our laboratory. On...
Gespeichert in:
Veröffentlicht in: | Journal of pharmaceutical sciences 1994-06, Vol.83 (6), p.763-767 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 767 |
---|---|
container_issue | 6 |
container_start_page | 763 |
container_title | Journal of pharmaceutical sciences |
container_volume | 83 |
creator | Huh, Kyongsang Schentag, Jerome J. Wilton, John H. Nix, David E. |
description | Aminoglycosides and penicillins chemically interact when they are combinedin vitroorin vivo.The resulting adducts are considered to be biologically inactive. The major adducts formed in the interaction between tobramycin and ticarcillin have been recently isolated in pure form in our laboratory. On the basis of mass, infrared, and proton magnetic resonance spectra, the major adducts appeared to be amides formed by an attack of the B‐lactam carbonyl group of ticarcillin by an amino group of tobramycin. All other moieties of ticarcillin were intact except that the β‐lactam ring was opened and was rotated by 120–130°. The minimum inhibitory concentrations (MICs) of the adducts, tobramycin, and ticarcillin were 20.0, 0.25, and 2.0 μg/mL forStaphylococcus aureusandEscherichia coli, and 160.0, 0.5, and 8.0 μg/mL forPseudomonas aeruginosa.Thus, the major adducts possessed some antimicrobial activity, but not enough to be active in the treatment of infections. As shown by fluorescence polarization immunoassay (FPIA), the adducts demonstrate some cross‐reactivity in the assay of tobramycin. However, it was insufficient to cause significant error in the measurement of tobramycin in human serum. |
doi_str_mv | 10.1002/jps.2600830602 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77133020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354915494985</els_id><sourcerecordid>77133020</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4562-d5dcd1e8ab796a14fba556328a278f6dd0e763263da135e0a7b20311aa4406b3</originalsourceid><addsrcrecordid>eNqFkM2O0zAURi0EGkphyw4pC8Qu5dqO7WRZBugwzPCjVmJpObaD7pAmxU4GuuMR5hl5kvEoVRELxMqy7vk-Xx9CnlJYUAD28moXF0wClBwksHtkRgWDXAJV98ksASznoqgekkcxXgEkRogTclJRBiXwGTlbD2G0wxh8zEznslfYt_1XtKbNlnbAaxwwTfom2_R1MNu9xe73r5tNAoLFtsUuWzqXCuJj8qAxbfRPDuecbN6-2Zye5RcfV-9Olxe5LYRkuRPOOupLU6tKGlo0tRFCclYapspGOgdepavkzlAuPBhVM-CUGlMUIGs-Jy-m2l3ov48-DnqL0fq2NZ3vx6iVopxDiszJYgJt6GMMvtG7gFsT9pqCvjOnkzn9x1wKPDs0j_XWuyN-UJXmzw9zE5OeJpjOYjxiBS3KCqqEVRP2A1u__8-j-vzT-q8V8imLcfA_j1kTvmmpuBL6y4eVLl-vPl_S9Xt9mfhy4n0Sfo0-6GjRd9Y7DN4O2vX4r9_eAt1cqVQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77133020</pqid></control><display><type>article</type><title>Structures and Biological Activities of Tobramycin‐Ticarcillin Adducts</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Huh, Kyongsang ; Schentag, Jerome J. ; Wilton, John H. ; Nix, David E.</creator><creatorcontrib>Huh, Kyongsang ; Schentag, Jerome J. ; Wilton, John H. ; Nix, David E.</creatorcontrib><description>Aminoglycosides and penicillins chemically interact when they are combinedin vitroorin vivo.The resulting adducts are considered to be biologically inactive. The major adducts formed in the interaction between tobramycin and ticarcillin have been recently isolated in pure form in our laboratory. On the basis of mass, infrared, and proton magnetic resonance spectra, the major adducts appeared to be amides formed by an attack of the B‐lactam carbonyl group of ticarcillin by an amino group of tobramycin. All other moieties of ticarcillin were intact except that the β‐lactam ring was opened and was rotated by 120–130°. The minimum inhibitory concentrations (MICs) of the adducts, tobramycin, and ticarcillin were 20.0, 0.25, and 2.0 μg/mL forStaphylococcus aureusandEscherichia coli, and 160.0, 0.5, and 8.0 μg/mL forPseudomonas aeruginosa.Thus, the major adducts possessed some antimicrobial activity, but not enough to be active in the treatment of infections. As shown by fluorescence polarization immunoassay (FPIA), the adducts demonstrate some cross‐reactivity in the assay of tobramycin. However, it was insufficient to cause significant error in the measurement of tobramycin in human serum.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.2600830602</identifier><identifier>PMID: 9120803</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>Washington: Elsevier Inc</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacteria - drug effects ; Biological and medical sciences ; Cross Reactions ; Humans ; Medical sciences ; Penicillins - pharmacology ; Pharmacology. Drug treatments ; Spectrophotometry ; Ticarcillin - chemistry ; Ticarcillin - pharmacology ; Tobramycin - chemistry ; Tobramycin - pharmacology</subject><ispartof>Journal of pharmaceutical sciences, 1994-06, Vol.83 (6), p.763-767</ispartof><rights>1994 Wiley-Liss, Inc., A Wiley Company</rights><rights>Copyright © 1994 Wiley‐Liss, Inc., A Wiley Company</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4562-d5dcd1e8ab796a14fba556328a278f6dd0e763263da135e0a7b20311aa4406b3</citedby><cites>FETCH-LOGICAL-c4562-d5dcd1e8ab796a14fba556328a278f6dd0e763263da135e0a7b20311aa4406b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.2600830602$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjps.2600830602$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4148909$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9120803$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huh, Kyongsang</creatorcontrib><creatorcontrib>Schentag, Jerome J.</creatorcontrib><creatorcontrib>Wilton, John H.</creatorcontrib><creatorcontrib>Nix, David E.</creatorcontrib><title>Structures and Biological Activities of Tobramycin‐Ticarcillin Adducts</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>Aminoglycosides and penicillins chemically interact when they are combinedin vitroorin vivo.The resulting adducts are considered to be biologically inactive. The major adducts formed in the interaction between tobramycin and ticarcillin have been recently isolated in pure form in our laboratory. On the basis of mass, infrared, and proton magnetic resonance spectra, the major adducts appeared to be amides formed by an attack of the B‐lactam carbonyl group of ticarcillin by an amino group of tobramycin. All other moieties of ticarcillin were intact except that the β‐lactam ring was opened and was rotated by 120–130°. The minimum inhibitory concentrations (MICs) of the adducts, tobramycin, and ticarcillin were 20.0, 0.25, and 2.0 μg/mL forStaphylococcus aureusandEscherichia coli, and 160.0, 0.5, and 8.0 μg/mL forPseudomonas aeruginosa.Thus, the major adducts possessed some antimicrobial activity, but not enough to be active in the treatment of infections. As shown by fluorescence polarization immunoassay (FPIA), the adducts demonstrate some cross‐reactivity in the assay of tobramycin. However, it was insufficient to cause significant error in the measurement of tobramycin in human serum.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacteria - drug effects</subject><subject>Biological and medical sciences</subject><subject>Cross Reactions</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Penicillins - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Spectrophotometry</subject><subject>Ticarcillin - chemistry</subject><subject>Ticarcillin - pharmacology</subject><subject>Tobramycin - chemistry</subject><subject>Tobramycin - pharmacology</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM2O0zAURi0EGkphyw4pC8Qu5dqO7WRZBugwzPCjVmJpObaD7pAmxU4GuuMR5hl5kvEoVRELxMqy7vk-Xx9CnlJYUAD28moXF0wClBwksHtkRgWDXAJV98ksASznoqgekkcxXgEkRogTclJRBiXwGTlbD2G0wxh8zEznslfYt_1XtKbNlnbAaxwwTfom2_R1MNu9xe73r5tNAoLFtsUuWzqXCuJj8qAxbfRPDuecbN6-2Zye5RcfV-9Olxe5LYRkuRPOOupLU6tKGlo0tRFCclYapspGOgdepavkzlAuPBhVM-CUGlMUIGs-Jy-m2l3ov48-DnqL0fq2NZ3vx6iVopxDiszJYgJt6GMMvtG7gFsT9pqCvjOnkzn9x1wKPDs0j_XWuyN-UJXmzw9zE5OeJpjOYjxiBS3KCqqEVRP2A1u__8-j-vzT-q8V8imLcfA_j1kTvmmpuBL6y4eVLl-vPl_S9Xt9mfhy4n0Sfo0-6GjRd9Y7DN4O2vX4r9_eAt1cqVQ</recordid><startdate>199406</startdate><enddate>199406</enddate><creator>Huh, Kyongsang</creator><creator>Schentag, Jerome J.</creator><creator>Wilton, John H.</creator><creator>Nix, David E.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199406</creationdate><title>Structures and Biological Activities of Tobramycin‐Ticarcillin Adducts</title><author>Huh, Kyongsang ; Schentag, Jerome J. ; Wilton, John H. ; Nix, David E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4562-d5dcd1e8ab796a14fba556328a278f6dd0e763263da135e0a7b20311aa4406b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacteria - drug effects</topic><topic>Biological and medical sciences</topic><topic>Cross Reactions</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Penicillins - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Spectrophotometry</topic><topic>Ticarcillin - chemistry</topic><topic>Ticarcillin - pharmacology</topic><topic>Tobramycin - chemistry</topic><topic>Tobramycin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huh, Kyongsang</creatorcontrib><creatorcontrib>Schentag, Jerome J.</creatorcontrib><creatorcontrib>Wilton, John H.</creatorcontrib><creatorcontrib>Nix, David E.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huh, Kyongsang</au><au>Schentag, Jerome J.</au><au>Wilton, John H.</au><au>Nix, David E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structures and Biological Activities of Tobramycin‐Ticarcillin Adducts</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>1994-06</date><risdate>1994</risdate><volume>83</volume><issue>6</issue><spage>763</spage><epage>767</epage><pages>763-767</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>Aminoglycosides and penicillins chemically interact when they are combinedin vitroorin vivo.The resulting adducts are considered to be biologically inactive. The major adducts formed in the interaction between tobramycin and ticarcillin have been recently isolated in pure form in our laboratory. On the basis of mass, infrared, and proton magnetic resonance spectra, the major adducts appeared to be amides formed by an attack of the B‐lactam carbonyl group of ticarcillin by an amino group of tobramycin. All other moieties of ticarcillin were intact except that the β‐lactam ring was opened and was rotated by 120–130°. The minimum inhibitory concentrations (MICs) of the adducts, tobramycin, and ticarcillin were 20.0, 0.25, and 2.0 μg/mL forStaphylococcus aureusandEscherichia coli, and 160.0, 0.5, and 8.0 μg/mL forPseudomonas aeruginosa.Thus, the major adducts possessed some antimicrobial activity, but not enough to be active in the treatment of infections. As shown by fluorescence polarization immunoassay (FPIA), the adducts demonstrate some cross‐reactivity in the assay of tobramycin. However, it was insufficient to cause significant error in the measurement of tobramycin in human serum.</abstract><cop>Washington</cop><pub>Elsevier Inc</pub><pmid>9120803</pmid><doi>10.1002/jps.2600830602</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3549 |
ispartof | Journal of pharmaceutical sciences, 1994-06, Vol.83 (6), p.763-767 |
issn | 0022-3549 1520-6017 |
language | eng |
recordid | cdi_proquest_miscellaneous_77133020 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection |
subjects | Anti-Bacterial Agents - pharmacology Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Bacteria - drug effects Biological and medical sciences Cross Reactions Humans Medical sciences Penicillins - pharmacology Pharmacology. Drug treatments Spectrophotometry Ticarcillin - chemistry Ticarcillin - pharmacology Tobramycin - chemistry Tobramycin - pharmacology |
title | Structures and Biological Activities of Tobramycin‐Ticarcillin Adducts |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T09%3A50%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structures%20and%20Biological%20Activities%20of%20Tobramycin%E2%80%90Ticarcillin%20Adducts&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Huh,%20Kyongsang&rft.date=1994-06&rft.volume=83&rft.issue=6&rft.spage=763&rft.epage=767&rft.pages=763-767&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.2600830602&rft_dat=%3Cproquest_cross%3E77133020%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77133020&rft_id=info:pmid/9120803&rft_els_id=S0022354915494985&rfr_iscdi=true |